BioCrossroads Report Spotlights Tech Transfer

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

BioCrossroads has released a report it says highlights the technology transfer efforts among Indiana’s top research universities. The state’s life sciences initiative says the report also reveals the increasing role of incubators and graduation facilities at research universities.

Patricia Martin, chief executive officer of BioCrossroads, says the state’s three R1 research institutions, Indiana University, Purdue University, and the University of Notre Dame, give Indiana “critical assets necessary to drive innovation.”

“Indiana universities or companies have played a vital role in tech transfer processes leading to the commercialization of insulin, treatment of prostate cancer, and reduction of cancer caused by the human papillomavirus among many others,” said Martin. “It’s critical that we continue to foster these programs to ensure the long-term competitiveness of Indiana’s life sciences sector.”

Tech transfer, according to the report, refers to “the process by which research-driven discoveries move from the laboratory such that they can be commercialized and accessed by the marketplace.”

Some of the universities’ tech transfer efforts highlighted in the report include:

• Since 1997, IU research has led to more than 4,800 global patent applications, generating more than $145 million in licensing and royalty income.
• Over the last five years, Purdue researchers have filed nearly 3,000 domestic and international patents, licensed more than 1,100 technologies, launched 112 companies, and generated nearly $36 million in royalty income.
• Since 2017, Notre Dame has started 64 companies. In 2019, the companies offered 99 full-time jobs paying an average salary of $72,000 (22% more than the average Indiana salary). They also raised an aggregate of $6.6 million in investment and are generating $10.9 million in revenue.

You can view the full report, Tech Transfer in Indiana: An Overview for the Life Sciences Industry, in the document below or by clicking here

 

.